A rating of 96 puts Surface Oncology Inc (SURF) near the top of the Biotechnology industry according to InvestorsObserver. Surface Oncology Inc's score of 96 means it scores higher than 96% of stocks in the industry. Surface Oncology Inc also received an overall rating of 78, putting it above 78% of all stocks. Biotechnology is ranked 70 out of the 148 industries.
SURF has an Overall Score of 78. Find out what this means to you and get the rest of the rankings on SURF!